Neeraj Kohli, MD, MBA, is a nationally and internationally recognized leader in the field of urogynecology and reconstructive pelvic surgery. He currently leads the BostonUrogyn team in Wellesley, Massachusetts.
Dr. Kohli received his undergraduate degree with a dual major in medical sciences and economics before completing his medical degree at Boston University School of Medicine.
Following his OB/GYN residency program at Beth Israel Hospital in Boston, Dr. Kohli entered Good Samaritan Hospital’s highly regarded fellowship in urogynecology and reconstructive pelvic surgery in Cincinnati, Ohio. Upon completion, Dr. Kohli remained as the associate director of the Division and Fellowship program, where he concentrated on teaching, clinical practice, and research.
In 1999, Dr. Kohli graduated with honors in his Executive MBA program at Northwestern’s Kellogg School of Management in Chicago. He then returned to Boston, where he was recruited to develop the urogynecology program at Boston’s Brigham and Women’s Hospital. Under his leadership, this program grew to become one of the most successful divisions in the OB/GYN department, with satellite locations at Newton-Wellesley Hospital, South Shore Hospital, and Exeter Hospital in New Hampshire.
In 2010, Dr. Kohli left Brigham and Women’s Hospital to start Boston Urogyn, where he’s the medical director. His multidisciplinary pelvic floor center is dedicated to state-of-the-art treatment, customer service, and personalized care.
During his career, Dr. Kohli has authored more than 100 scientific articles, book chapters, research abstracts, clinical presentations, and multimedia educational tools. His current interests include minimally invasive pelvic surgery and advanced technologies for the treatment of prolapse, incontinence, and pelvic pain.
Dr. Kohli also teaches students, residents, and fellows within the Harvard Medical School system and medical colleagues nationwide. His many research interests include the cost efficiency of minimally invasive surgical techniques, obstetric risk factors for pelvic floor dysfunction, and the clinical application of urodynamic testing.
